Combination with gamma secretase inhibitor prolongs treatment efficacy of BRAF inhibitor in BRAF mutant melanoma cells

被引：0
|
作者：
Zhu, G. [1 ,2 ]
Yi, X. [1 ]
Haferkamp, S. [3 ]
Hesbacher, S. [2 ]
Li, C. [1 ]
Goebeler, M. [2 ]
Gao, T. [1 ]
Houben, R. [2 ]
Schrama, D. [2 ]
机构：
[1] Fourth Mil Med Univ, Dermatol, Xian, Peoples R China
[2] Univ Hosp Wurzburg, Dermatol, Wurzburg, Germany
[3] Univ Regensburg, Dermatol, Regensburg, Germany
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2016年 / 136卷 / 05期
关键词：
D O I：
10.1016/j.jid.2016.02.699
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
658
引用
收藏
页码：S116 / S116
页数：1
相关论文
共 50 条
  • [21] Combination therapy for melanoma with BRAF/MEK inhibitor and immune checkpoint inhibitor: a mathematical model
    Lai, Xiulan
    Friedman, Avner
    BMC SYSTEMS BIOLOGY, 2017, 11
  • [22] Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
    Gideon Bollag
    Peter Hirth
    James Tsai
    Jiazhong Zhang
    Prabha N. Ibrahim
    Hanna Cho
    Wayne Spevak
    Chao Zhang
    Ying Zhang
    Gaston Habets
    Elizabeth A. Burton
    Bernice Wong
    Garson Tsang
    Brian L. West
    Ben Powell
    Rafe Shellooe
    Adhirai Marimuthu
    Hoa Nguyen
    Kam Y. J. Zhang
    Dean R. Artis
    Joseph Schlessinger
    Fei Su
    Brian Higgins
    Raman Iyer
    Kurt D’Andrea
    Astrid Koehler
    Michael Stumm
    Paul S. Lin
    Richard J. Lee
    Joseph Grippo
    Igor Puzanov
    Kevin B. Kim
    Antoni Ribas
    Grant A. McArthur
    Jeffrey A. Sosman
    Paul B. Chapman
    Keith T. Flaherty
    Xiaowei Xu
    Katherine L. Nathanson
    Keith Nolop
    Nature, 2010, 467 : 596 - 599
  • [23] Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitor
    Nadja A. Galliker
    Carla Murer
    Jivko Kamarashev
    Reinhard Dummer
    Simone M. Goldinger
    European Journal of Dermatology, 2015, 25 : 177 - 180
  • [24] Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitor
    Galliker, Nadja A.
    Murer, Carla
    Kamarashev, Jivko
    Dummer, Reinhard
    Goldinger, Simone M.
    EUROPEAN JOURNAL OF DERMATOLOGY, 2015, 25 (02) : 177 - 180
  • [25] Overcoming BRAF Inhibitor Resistance in Melanoma
    Smalley, Keiran
    Fedorenko, Inna
    Paraiso, Kim H.
    Flach, Edward
    Anderson, Alexander R.
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (08) : 910 - 910
  • [26] Inhibition of FGF-Receptors for effective treatment of BRAF and BRAF/MEK inhibitor-resistant melanoma cells
    Graf, S.
    Hamel, A.
    Meierjohann, S.
    Heppt, M.
    Kammerbauer, C.
    Berking, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 7 - 7
  • [27] OVERCOMING BRAF INHIBITOR RESISTANCE IN MELANOMA
    Chan, Xian Yang
    Brassington, Kurt
    Darby, Ian A.
    Piva, Terrence J.
    WOUND REPAIR AND REGENERATION, 2016, 24 (06) : A26 - A26
  • [28] THE ROLE OF SOD2 AND ROS IN BRAF/MEK INHIBITOR RESISTANCE IN BRAF MUTANT MELANOMA.
    Yuan, L.
    Mishra, R.
    Patel, H.
    Alanazi, S.
    Wei, X.
    Ma, Z.
    Garrett, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S53 - S53
  • [29] Inhibition of FGF receptors for effective treatment of BRAF- and BRAF/MEK inhibitor-resistant melanoma cells
    Graf, S. A.
    Strieder, A.
    Meierjohann, S.
    Heppt, M. V.
    Kammerbauer, C.
    Berking, C.
    EXPERIMENTAL DERMATOLOGY, 2017, 26 (03) : E92 - E92
  • [30] The CSPG4-specific monoclonal antibody enhances and prolongs the effects of the BRAF inhibitor in melanoma cells
    Ling Yu
    Elvira Favoino
    Yangyang Wang
    Yang Ma
    Xiaojuan Deng
    Xinhui Wang
    Immunologic Research, 2011, 50 : 294 - 302
12345